01/03/2019 @ 11:33AM - US Cannabis Health LOI with
Post# of 214
"Generex Biotechnology has also stepped forward in the rapidly evolving and growing cannabis based therapies sector entering into an LOI with US Cannabis Health , a JV between Puration, inc. (PURA), Kali-Extracts, Inc. (KALY) and Nouveau Life Pharmaceuticals, Inc. (NOUV) . The LOI includes an agreement for KALY to produce specialized CBD extracts for infusion into a bottled water to be produced by PURA under a private label for Generex."
Generex Biotechnology Makes Major Advance On $22 Billion Wound Care Market Announcing Milestone Agreement
https://ih.advfn.com/stock-market/USOTC/gener...ce-on-22-b